Evidence map›Paper›PMID 42776977›Full record

ArticlePLoS medicine2026

Evaluation of the tuberculosis notification impact from an intermediary-facilitated public-private mix intervention in Viet Nam: A population-level quasi-experimental study.

Luan Nguyen Quang Vo, Thuy Thi Thu Dong, Huy Ba Huynh, Binh Anh Luong, Huong Thi Lan Mo, Andrew James Codlin, Rachel Forse, Thuy Doan To Mai, Lan Phuong Nguyen, Jacob Creswell and 19 more

Abstract read
In one paragraph

Article in PLoS medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Luan Nguyen Quang VoFriends for International TB Relief, Ha Noi, Viet Nam.ORCID https://orcid.org/0000-0002-5937-6286
Thuy Thi Thu DongFriends for International TB Relief, Ha Noi, Viet Nam.
Huy Ba HuynhFriends for International TB Relief, Ha Noi, Viet Nam.
Binh Anh LuongUniversity of Sydney Vietnam Institute, Ho Chi Minh City, Viet Nam.
Huong Thi Lan MoFriends for International TB Relief, Ha Noi, Viet Nam.ORCID https://orcid.org/0009-0005-0373-1540
Andrew James CodlinFriends for International TB Relief, Ha Noi, Viet Nam.ORCID https://orcid.org/0000-0003-1380-8300
Rachel ForseFriends for International TB Relief, Ha Noi, Viet Nam.ORCID https://orcid.org/0000-0002-0716-3342
Thuy Doan To MaiFriends for International TB Relief, Ha Noi, Viet Nam.ORCID https://orcid.org/0009-0000-4319-9994
Lan Phuong NguyenFriends for International TB Relief, Ha Noi, Viet Nam.ORCID https://orcid.org/0000-0002-5862-9544
Jacob CreswellStop TB Partnership, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-4885-940X
Luong Van DinhNational Lung Hospital, Ha Noi, Viet Nam.
Hoa Binh NguyenNational Lung Hospital, Ha Noi, Viet Nam.ORCID https://orcid.org/0000-0002-1543-4907
Phu Xuan VuNational Lung Hospital, Ha Noi, Viet Nam.
Tuan Dinh NguyenNational Lung Hospital, Ha Noi, Viet Nam.ORCID https://orcid.org/0009-0007-1007-7692
Lan Huu NguyenPham Ngoc Thach Hospital, Ho Chi Minh City, Viet Nam.
Thi Minh Ha DangPham Ngoc Thach Hospital, Ho Chi Minh City, Viet Nam.
Son Van LuuNational Lung Hospital, Ha Noi, Viet Nam.
Nam Hoang DoNational Lung Hospital, Ha Noi, Viet Nam.ORCID https://orcid.org/0000-0001-8246-4674
Huyen Thanh TruongNational Lung Hospital, Ha Noi, Viet Nam.
Phan Do NguyenNational Lung Hospital, Ha Noi, Viet Nam.ORCID https://orcid.org/0009-0008-3829-2885
Tushar GargStop TB Partnership, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-6781-8574
Jad ShedrawyThe Swedish Institute for Health Economics, Stockholm, Sweden.
Kristi Sidney AnnerstedtDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-8798-4027
Minh Huy PhamUnited States Agency for International Development, Ha Noi, Viet Nam.ORCID https://orcid.org/0009-0008-7703-3544
Jamie TonsingGlobal Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.ORCID https://orcid.org/0009-0006-6211-2982
Tom WingfieldCentre for Tuberculosis Research, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID https://orcid.org/0000-0001-8433-6887
Mohammed Ahmed YassinGlobal Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-9766-2072
Nhung Viet NguyenVNU University of Medicine and Pharmacy, Ha Noi, Viet Nam.ORCID https://orcid.org/0000-0002-5447-133X
Knut LönnrothDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTreatment coverage gaps remain a major barrier to ending tuberculosis (TB). Public-private mix (PPM) entails the engagement of healthcare providers outside of national TB programs (NTP). PPM strategies are promoted to improve TB notification, particularly in high-burden settings with fragmented care systems, and intermediary agencies are recognized as effective mechanisms to operationalize PPM by bridging NTPs and out-of-network healthcare providers. However, population-level evidence is rare, as most evaluations have been limited to pilot studies, small geographic areas, or uncontrolled designs. This study documents the population-level association of a PPM intervention with TB notifications through the use of unbiased analytical methods to account for heterogeneity from the intervention's staggered deployment and dynamic intensity. METHODS AND

findingsWe present a non-randomized, quasi-experimental evaluation of a large-scale intermediary-facilitated PPM intervention conducted between 2020 and 2023 in 15 provinces of Viet Nam, covering 40.6 million people equivalent to 40% of the population. The intervention engaged 3,154 non-NTP providers in TB care, linking them to the NTP through systematic screening, referral, and reporting mechanisms. The model emphasized active case finding, provider incentives, patient support and integrated data systems to raise notifications as the primary outcome. We analyzed quarterly province-level TB notification data from 2016 to 2025 using a heterogeneity-robust extended two-way fixed-effects framework to estimate the average treatment effect on the treated. The analysis adjusted for province and calendar-quarter fixed effects, and for COVID-19 disruptions. Using Poisson pseudo-maximum-likelihood fixed-effects models, we estimated dose-response effects and post-intervention patterns and triangulated effects with an interrupted time-series analysis of national notifications and repeated all analyses using the intermediate outcome of PPM notifications. Lastly, we calculated marginal cost per additional notification from a funder perspective. The intervention was associated with 316.8 additional notifications per province-quarter (95% confidence interval [CI] [23.4, 610.2]; p = 0.034). Regarding dose-response effects, we observed a 1.4% increase in notifications per 100 verbal assessments per 100,000 population (incidence rate ratio [IRR]=1.00014; 95% CI [1.00002, 1.00025]; p = 0.018). National models suggested 3,206 (95% CI [1,658, 4,763]; p < 0.001) additional notifications annually with a 3.5% intensity-associated notification increase (IRR = 1.00035; 95% CI [1.00018, 1.00052]; p < 0.001). Using PPM notifications produced concordant results. The costs per additional notification were US$ 166-US$ 458. The main limitation was the non-randomized design, with high-burden provinces purposively selected as intervention areas. This was mitigated through conservative control selection and triangulation across methods.

conclusionsThis study furnishes robust, policy-relevant evidence that intermediary-facilitated PPM implemented at scale in Viet Nam was associated with significant, dose-responsive increases in PPM and TB notifications at provincial and national levels. These findings promote intermediary agency models as an effective mechanism to operationalize PPM at scale and to generate public health benefits in closing TB treatment coverage gaps. In an era of constrained global health financing, leveraging existing provider networks through intermediary-facilitated PPM offers an affordable and scalable strategy to sustain momentum towards ending TB.

Indexed as

Public-Private Sector PartnershipsTuberculosisDisease NotificationHumansVietnam

Identifiers

PMID42776977
PMCPMC13600524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.